Aspenpharma
About Aspenpharma
Aspenpharma is a Healthcare company based in Japan, and was acquired by Sandoz in January 2020. Pharmaceutical operations are conducted by Aspenpharma in Japan.
Company details
Headquarters of Aspenpharma are situated in Japan, with operations focused on the pharmaceutical sector. Development and distribution of medicinal products are handled through the companys infrastructure. Services related to drug manufacturing and supply are provided to healthcare providers in the region. The domain aspenpharma.co.jp indicates a primary emphasis on Japanese markets, where regulatory compliance and local partnerships are maintained for ongoing activities.
- Headquarters Japan
- Stage Acquired
- SectorsHealthcare
- Website aspenpharma.co.jp
- Acquired by Sandoz (Jan 2020)
Investors in Aspenpharma
Aspenpharma has secured backing from 1 investor. Prominent investors backing the company include Sandoz.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Generic and biosimilar pharmaceuticals are developed and distributed globally. | 1886 | sandoz.com | Holzkirchen, Germany |
Investor details for Aspenpharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Aspenpharma
Aspenpharma is headquartered in Japan.
Headquarters of Aspenpharma are situated in Japan, with operations focused on the pharmaceutical sector. Development and distribution of medicinal products are handled through the companys infrastructure. Services related to drug manufacturing and supply are provided to healthcare providers in the region. The domain aspenpharma.co.jp indicates a primary emphasis on Japanese markets, where regulatory compliance and local partnerships are maintained for ongoing activities.
Aspenpharma has 1 investor. Key investors include Sandoz.
Yes. Aspenpharma was acquired by Sandoz in January 2020.